“CLINICAL AND ENDOSCOPIC EVALUATION OF THE EFFICACY OF INTRANASAL MOMETASONE FUROATE IN CHILDREN WITH ADENOID HYPERTROPHY”

Authors

  • Otajonov Iqrorjon Baxtiyorjon o’g’li Author

Keywords:

adenoid, treatment, nasal, obstruction, children, hypertrophy, symptoms, clinical, intranasal, tissue

Abstract

Adenoid hypertrophy is a frequent cause of chronic nasal obstruction and impaired nasal breathing in children. Enlarged adenoid tissue can obstruct the choanae and the nasopharyngeal airway, resulting in mouth breathing, snoring, sleep disturbances, recurrent upper respiratory tract infections, and impaired quality of life. Although adenotomy remains the standard surgical treatment for severe symptomatic cases, conservative treatment with intranasal corticosteroids may reduce symptoms and adenoid tissue enlargement in selected patients.

References

1. Paradise JL, Bluestone CD, Colborn DK, Bernard BS, Rockette HE, Kurs-Lasky M.

Efficacy of adenoidectomy for recurrent throat infection in moderately affected

children. New England Journal of Medicine. 2001

344(15):1187–1195.

2. Brietzke SE, Brigger MT. Adenoidectomy outcomes in pediatric patients with chronic

nasal obstruction: a systematic review. Otolaryngology–Head and Neck Surgery.

2009

140(6):769–774.

3. van den Aardweg MTA, Boonacker CWB, Rovers MM, Hoes AW, Schilder AGM.

Effectiveness of adenoidectomy in children with recurrent upper respiratory tract

infections: open randomised controlled trial. BMJ. 2011

343:d5154.

4. Georgalas C, Tolley N, Narula A. Tonsillitis and adenoiditis. BMJ Clinical Evidence.

2009

2009:509.

5. Lesinskas E, Drigotas M. The effect of adenoidectomy on quality of life in children

with adenotonsillar hypertrophy. Medicina (Kaunas). 2009

45(3):205–210.

6. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children

with adenoidal hypertrophy. International Journal of Pediatric Otorhinolaryngology.

2006

70(4):639–645.

7. Demirhan H, Aksoy F, Ozturan O, Yildirim YS, Veyseller B, Altuntas A. Medical

treatment of adenoid hypertrophy with mometasone furoate nasal spray. International

Journal of Pediatric Otorhinolaryngology. 2010

74(7):773–777.

8. Zhang L, Mendoza-Sassi RA, César JA, Chadha NK. Intranasal corticosteroids for

nasal airway obstruction in children with moderate to severe adenoid hypertrophy.

Cochrane Database of Systematic Reviews. 2008

(3):CD006286.

9. Chohan A, Lal A, Dhingra S, et al. Intranasal corticosteroids for improving nasal

airway obstruction in children with moderate to severe adenoid hypertrophy. Cochrane

Database of Systematic Reviews. 2020.

10.Feres MFN, Hermann JS, Cappellette M Jr, et al. Endoscopic evaluation of adenoid

hypertrophy in children: correlation with clinical symptoms. International Journal of

Pediatric Otorhinolaryngology.

11.Modrzynski M, Zawisza E. An analysis of the relationship between nasal obstruction

and adenoid hypertrophy in children. International Journal of Pediatric

Otorhinolaryngology.

12.Yilmaz M, Titiz A, Ozcan M, et al. Evaluation of adenoid hypertrophy by nasal

endoscopy and its relationship with clinical symptoms. American Journal of Rhinology.

13.Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis

and Nasal Polyps 2020. Rhinology. 2020

58(Suppl S29):1–464.

14.Brook I. Microbiology and management of upper respiratory tract infections in

children. International Journal of Pediatric Otorhinolaryngology.

15.Isaac A, Major M, Alsaffar H, et al. Endoscopic assessment of adenoid hypertrophy

and its relationship to symptoms in pediatric patients. Otolaryngology–Head and Neck

Surgery

Published

2026-09-07